Summit Creek Advisors’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-196,316
Closed -$1.86M 69
2025
Q1
$1.86M Sell
196,316
-5,798
-3% -$58.6K 0.27% 53
2024
Q4
$2.27M Buy
202,114
+1,636
+0.8% +$28.8K 0.3% 50
2024
Q3
$5.67M Sell
200,478
-342,763
-63% -$8.83M 0.77% 47
2024
Q2
$10.4M Sell
543,241
-30,527
-5% -$780K 1.42% 35
2024
Q1
$18.8M Buy
573,768
+3,408
+0.6% +$109K 2.37% 19
2023
Q4
$18.8M Buy
570,360
+10,865
+2% +$307K 2.52% 15
2023
Q3
$15.2M Buy
559,495
+2,425
+0.4% +$67.4K 2.07% 21
2023
Q2
$16.9M Buy
557,070
+52,965
+11% +$1.71M 2.11% 17
2023
Q1
$16.4M Buy
504,105
+75,293
+18% +$2.38M 2.13% 20
2022
Q4
$12M Buy
428,812
+960
+0.2% +$27.5K 1.64% 28
2022
Q3
$15.4M Sell
427,852
-13,606
-3% -$479K 2.12% 25
2022
Q2
$13.6M Sell
441,458
-4,240
-1% -$124K 1.73% 29
2022
Q1
$14.4M Buy
445,698
+21,746
+5% +$569K 1.63% 31
2021
Q4
$11.7M Buy
423,952
+196,656
+87% +$5.64M 1.18% 39
2021
Q3
$7.05M Buy
227,296
+15,650
+7% +$376K 0.75% 49
2021
Q2
$4.47M Buy
+211,646
New +$4.24M 0.53% 52

Other funds holding EVH

Summit Creek Advisors's EVH Position: Q2 2025 in Review

Summit Creek Advisors sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 196,316 shares — an estimated $1.86M sold.

Summit Creek Advisors first reported a position in EVH in Q2 2021 and held it in 16 quarters. The position peaked at $18.8M in Q4 2023. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • Summit Creek Advisors reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • Summit Creek Advisors sold 196,316 Evolent Health shares in Q2 2025, an estimated $1.86M.
  • Summit Creek Advisors first reported a position in Evolent Health in Q2 2021 and held it in 16 quarters.
  • Summit Creek Advisors's Evolent Health position peaked at $18.8M in Q4 2023.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on Summit Creek Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.